SMS PHARMACEUTICALS LTD. - 532815 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation for the third quarter ended 31st December, 202310-02-2024
10-02-2024
SMS Pharma to raise 114 crore through warrants issue
Shares of the drugmaker up 12% at 146.6009-02-2024
SMS PHARMACEUTICALS LTD. - 532815 - Update In Code Of Practices And Procedures For Fair Disclosure Of Unpublished Price Sensitive Information
updated code of practices and procedures for fair disclosure of unpublished price sensitive information08-02-2024
SMS PHARMACEUTICALS LTD. - 532815 - Announcement under Regulation 30 (LODR)-Preferential Issue
Approval for fund raising by way of issue of warrants on preferential basis08-02-2024
SMS PHARMACEUTICALS LTD. - 532815 - Financial Results For The Quarter Ended 31St December, 2023
Financial Results for the quarter ended 31st December, 202308-02-2024
SMS PHARMACEUTICALS LTD. - 532815 - Board Meeting Outcome for Outcome Of The Board Meeting - Approval Of Financial Results For The Quarter Ended 31St December, 2023 And Approval For Issue Of Share Warrants On Preferential Basis
Outcome of the Board Meeting - Approval of financial results for the quarter ended 31st December, 2023 and approval for issue of share warrants on preferential basis08-02-2024
SMS PHARMACEUTICALS LTD. - 532815 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
we are enclosing here with invitation for Investor's Conference Call, scheduled to be held on Monday, 12th February, 2024 at 04:00 P.M. (IST), to discuss the Company's financial performance for the third quarter ended 31st December, 2023.07-02-2024
SMS PHARMACEUTICALS LTD. - 532815 - Update on board meeting
SMS PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/02/2024 ,inter alia, to consider and approve Update on board meeting the Board of Directors of the Company inter-alia shall also consider the proposal for fund raising by way of issue of equity shares/ warrants and/or any other instruments/ securities on preferential basis05-02-2024
SMS PHARMACEUTICALS LTD. - 532815 - Board Meeting Intimation for Approval Of Financial Results For The Quarter Ended On 31St December, 2023
SMS PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/02/2024 ,inter alia, to consider and approve the Financial Results of the Company for the third quarter ended on 31st December, 202302-02-2024
SMS PHARMACEUTICALS LTD. - 532815 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
We are herewith enclosing the Certificate received from RTA of the Company for the quarter ended December 31, 2023.10-01-2024